Subclinical Macular Edema as a predictor of progression to Clinically Significant Macular Edema in Diabetes type 2
Subclinical Macular Edema as a predictor of progression to Clinically Significant Macular Edema in Diabetes type 2
Pires, I., Santos, A., Nunes, S., Lobo, C., Cunha-Vaz, J.
Ophthalmologica 230(4):201-6, 2013
2013
Choroidal thickness after treatment for myopic choroidal neovascularization
Choroidal thickness after treatment for myopic choroidal neovascularization
Farinha, C.L., Baltar, A.S., Nunes, S.G., Franqueira, N.F., Figueira, J.P., Pires, I.A., Cachulo, M.L., Silva, R.M.
Eur J Ophthalmol 2013 Jun 13:0; DOI: 10,5301/ejo.5000323
2013
Degree of Decrease in Central Retinal Thickness Predicts Visual Acuity Response to Intravitreal Ranibizumab in Diabetic Macular Edema
Degree of Decrease in Central Retinal Thickness Predicts Visual Acuity Response to Intravitreal Ranibizumab in Diabetic Macular Edema
Santos A.R., Gomes S.C., Figueira J., Nunes S., Lobo C.L., Cunha-Vaz J.G.
Ophthalmologica 2013; DOI: 10.1159/000355487
2013
Biomarkers of Diabetic Retinopathy
Biomarkers of Diabetic Retinopathy
Cunha-Vaz J, Ribeiro L, Nunes S, Lobo C.
Diabetes Manage 2014; 4(2), 181-192
2014
Degree of decrease in central retinal thickness predicts visual acuity response to intravitreal ranibizumab in diabetic macular edema.
Degree of decrease in central retinal thickness predicts visual acuity response to intravitreal ranibizumab in diabetic macular edema.
Santos AR; Gomes SC; Figueira J; Nunes S; Lobo CL; Cunha-Vaz JG
Ophthalmologica. 2014;231(1):16-22.
2014
Neurodegeneration in the diabetic Eye: new insights and terapeutic perspectives.
Neurodegeneration in the diabetic Eye: new insights and terapeutic perspectives.
Simó R; Hernández C; European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR); Collaborators (17).
Trends Endocrinol Metab. 20104 Jan; 25(1):23-33. Epub 2013
2014
Drug-safety alerts issued by regulatory authorities: usefulness of meta-analysis in predicting earlier risks
Drug-safety alerts issued by regulatory authorities: usefulness of meta-analysis in predicting earlier risks
Carlos Alves, Francisco Batel Marques, Ana Filipa Macedo
European Journal of Clinical Pharmacology 2014. DOI:10.1007/s00228-014-1670-5
2014
Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System
Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System
Marques JP, Costa MA, Melo P, Oliveira C, Pires I, Cachulo ML, Figueira J, Silva R
ISRN Ophthalmology, vol. 2013, Article ID 464218, 8 pages, 2013. doi:10.1155/2013/464218
2013
Sources of information used by regulatory agencies on the generation of drug safety alerts.
Sources of information used by regulatory agencies on the generation of drug safety alerts.
Carlos Alves, Ana Filipa Macedo, Francisco Batel Marques
Eur J Clin Pharmacol. 2013;69(12):2083-94.
2013
Safety of biologics approved for treating rheumatoid arthritis: analysis of spontaneous reports of adverse events.
Safety of biologics approved for treating rheumatoid arthritis: analysis of spontaneous reports of adverse events.
Diogo Mendes, Carlos Alves, Francisco Batel Marques
Clin Rheumatol. 2013;32(8):1207-14.
2013
